155 related articles for article (PubMed ID: 38450420)
21. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
[TBL] [Abstract][Full Text] [Related]
22. Screening mammography for second breast cancers in women with history of early-stage breast cancer: factors and causes associated with non-detection.
Yeom YK; Chae EY; Kim HH; Cha JH; Shin HJ; Choi WJ
BMC Med Imaging; 2019 Jan; 19(1):2. PubMed ID: 30611228
[TBL] [Abstract][Full Text] [Related]
23. Screening Mammography Performance Metrics of 2D Digital Mammography Versus Digital Breast Tomosynthesis in Women With a Personal History of Breast Cancer.
Chikarmane SA; Cochon LR; Khorasani R; Sahu S; Giess CS
AJR Am J Roentgenol; 2021 Sep; 217(3):587-594. PubMed ID: 32966113
[No Abstract] [Full Text] [Related]
24. Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in Canada.
Seely JM; Peddle SE; Yang H; Chiarelli AM; McCallum M; Narasimhan G; Zakaria D; Earle CC; Fung S; Bryant H; Nicholson E; Politis C; Berg WA
Can Assoc Radiol J; 2022 Feb; 73(1):90-100. PubMed ID: 34279132
[TBL] [Abstract][Full Text] [Related]
25. Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review.
Robertson C; Ragupathy SK; Boachie C; Fraser C; Heys SD; Maclennan G; Mowatt G; Thomas RE; Gilbert FJ;
Eur Radiol; 2011 Dec; 21(12):2484-91. PubMed ID: 21833567
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
27. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
28. The importance of mammographic screening relative to the treatment of women with carcinoma of the breast.
Solin LJ; Legorreta A; Schultz DJ; Zatz S; Goodman RL
Arch Intern Med; 1994 Apr; 154(7):745-52. PubMed ID: 8147678
[TBL] [Abstract][Full Text] [Related]
29. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
30. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy.
Kini VR; Vicini FA; Frazier R; Victor SJ; Wimbish K; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):341-6. PubMed ID: 10030259
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of post-lumpectomy recurrence rates: is follow-up every 6 months for 2 years needed?
McNaul D; Darke M; Garg M; Dale P
J Surg Oncol; 2013 May; 107(6):597-601. PubMed ID: 23280430
[TBL] [Abstract][Full Text] [Related]
32. Mammographic surveillance of breast cancer patients: should the mastectomy site be imaged?
Fajardo LL; Roberts CC; Hunt KR
AJR Am J Roentgenol; 1993 Nov; 161(5):953-5. PubMed ID: 8273633
[TBL] [Abstract][Full Text] [Related]
33. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
34. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery.
Cil T; Fishell E; Hanna W; Sun P; Rawlinson E; Narod SA; McCready DR
Cancer; 2009 Dec; 115(24):5780-7. PubMed ID: 19902459
[TBL] [Abstract][Full Text] [Related]
35. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
36. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
[TBL] [Abstract][Full Text] [Related]
37. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
Bailey SL; Sigal BM; Plevritis SK
J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
[TBL] [Abstract][Full Text] [Related]
38. Effects of nonparticipation at previous screening rounds on the characteristics of screen-detected breast cancers.
Duijm LEM; Broeders MJM; Setz-Pels W; van Breest Smallenburg V; van Beek HC; Donkers-van Rossum AB; Slob MJ; Kuipers TP; Mann RM; Voogd AC
Eur J Radiol; 2022 Sep; 154():110391. PubMed ID: 35679699
[TBL] [Abstract][Full Text] [Related]
39. Surveillance of women with a personal history of breast cancer by tumour subtype.
Benveniste AP; Dryden MJ; Bedrosian I; Morrow PK; Bassett RL; Yang W
Clin Radiol; 2017 Mar; 72(3):266.e1-266.e6. PubMed ID: 28341031
[TBL] [Abstract][Full Text] [Related]
40. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
